Matthew J Budoff is an expert in Cardiology at Harbor–UCLA Medical Center (United States). As of October 2026, ScienceLeadR ranks Matthew J Budoff in the top 1% of experts worldwide for Arterial Occlusive Diseases, Arteriosclerosis and Coronary Disease. Matthew J Budoff has authored 2,748 publications, the most recent in 2026, and is an investigator in 68 clinical trials, 6 of them ongoing. SLR score: 9,522 (community average: 125). How the SLR is computed.

LeadR Profile

Matthew J Budoff Harbor–UCLA Medical Center United States
9 522 ScienceLeadR Reputation 9522
Network Map

Cardiology

Subspecialties: Medical Imaging - Public Health - Endocrinology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1995 - 2026

Source: PubMed

Harbor–UCLA Medical Center

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Development and Validation of a Coronary Artery Calcium Volume and Density Score.
PMID 42861496 — cardiovascular diseases, blood pressure, aspirin, arteries, diagnostic imaging, calcium, primary prevention, demography
Circ Cardiovasc Imaging20260
Rapid progression of coronary atherosclerosis across glycemic status: a serial coronary computed tomography angiography study from the PARADIGM registry.
PMID 42850638 — diabetes mellitus, registries, incidence, tomography, angiography, prediabetic state, atherosclerosis, computed tomography angiography
Cardiovasc Diabetol20260
Improved plaque composition from intensive medical treatment in women with angina and non-obstructive coronary disease.
PMID 42841236 — coronary disease, therapeutics, hydroxymethylglutaryl-coa reductase inhibitors
Cardiovasc Res20260
Agatston-2.0: A next-generation AI-based coronary calcium quantification approach to improve risk stratification among individuals with zero Agatston scores - Part I: An AI-CVD Study within the Multi-Ethnic Study of Atherosclerosis and Framingham Heart Study.
PMID 42828238 — heart, multiple chronic conditions, calcium, atherosclerosis, artificial intelligence
Am J Prev Cardiol20262
Regulators of Mineralization and Long-Term Progression of Aortic Valve and Mitral Annular Calcification: MESA.
PMID 42786596 — heart diseases, incidence, vitamins, fetuins, aortic valve
J Am Heart Assoc20260

Clinical Studies 68

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4

By phase:

Phase 3 28
N/A 25
Phase 4 10
Phase 2 5

By status:

Completed 49
Active not recruiting 10
Recruiting 3
Unknown 3
Terminated 2
Enrolling by invitation 1

By type:

Interventional 51
Observational 17

By Monocentric/Multicentric:

monocentric 29
multicentric2to4 3
multicentric5to9 2
multicentricup10 34

Main Topics

Cohort/Consortium Investigators 17

Ongoing Clinical Trials

6 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
NCT07521007 — safety, coronary artery disease, arteries, atherosclerosis
Phase 2Recruiting2026
Efficacy Safety and PopPK Profile of ABP 745 in Patients With Atherosclerosis
NCT07303777 — safety, cardiovascular diseases, tablets, atherosclerosis, pharmacokinetics
Phase 2Recruiting2026
Effect of Colchicine on Progression of Known Coronary Atherosclerosis in Patients With Stable Coronary Artery Disease
NCT06342609 — myocardial ischemia, coronary artery disease, colchicine, arteries, coronary disease, atherosclerosis, ischemia
Phase 4Active not recruiting2023
A CCTA Imaging Trial to Evaluate the Effect of Obicetrapib Ezetimibe on Coronary Plaque
NCT06305559 — ezetimibe, hyperlipidemias, coronary artery disease, cardiovascular diseases, angiography, arteries, therapeutics, plaque, atherosclerotic, computed tomography angiography, lipids
Phase 3Active not recruiting2024
Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
NCT05708859 — diabetes mellitus, myocardial ischemia, coronary artery disease, arteries, solutions, atherosclerosis, ischemia, diabetes mellitus, type 2
Phase 4Recruiting2024

LeadR Networks

Main global connection map